Fidelity Investments
VERA icon

Fidelity Investments’s Vera Therapeutics VERA Stock Holding History

Fidelity Investments’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$119M Buy
2,774,070
+97,648
+4% +$3.64M 0.01% 1166
2026
Q1 		$108M Sell
2,676,422
-209,431
-7% -$9.02M 0.01% 1139
2025
Q4 		$146M Buy
2,885,853
+42,722
+2% +$1.52M 0.01% 1011
2025
Q3 		$82.6M Sell
2,843,131
-66,833
-2% -$1.55M ﹤0.01% 1258
2025
Q2 		$68.6M Sell
2,909,964
-322,355
-10% -$7.25M ﹤0.01% 1268
2025
Q1 		$77.6M Buy
3,232,319
+179,193
+6% +$5.76M 0.01% 1190
2024
Q4 		$129M Buy
3,053,126
+267,842
+10% +$11.9M 0.01% 1009
2024
Q3 		$123M Sell
2,785,284
-16,654
-0.6% -$632K 0.01% 1013
2024
Q2 		$101M Sell
2,801,938
-321,330
-10% -$12.7M 0.01% 1035
2024
Q1 		$135M Buy
3,123,268
+348,896
+13% +$12.4M 0.01% 940
2023
Q4 		$42.7M Sell
2,774,372
-2,670,994
-49% -$33.9M ﹤0.01% 1350
2023
Q3 		$74.7M Sell
5,445,366
-1,090,194
-17% -$18.7M 0.01% 1094
2023
Q2 		$105M Buy
6,535,560
+739,301
+13% +$6.68M 0.01% 973
2023
Q1 		$45M Buy
5,796,259
+1,647,613
+40% +$12.7M ﹤0.01% 1302
2022
Q4 		$80.3M Buy
4,148,646
+92,305
+2% +$1.67M 0.01% 1056
2022
Q3 		$86.4M Buy
4,056,341
+40,990
+1% +$767K 0.01% 1010
2022
Q2 		$54.6M Buy
4,015,351
+3,321
+0.1% +$58K 0.01% 1221
2022
Q1 		$94.2M Buy
4,012,030
+866,828
+28% +$18.7M 0.01% 1089
2021
Q4 		$84M Buy
3,145,202
+5,800
+0.2% +$128K 0.01% 1190
2021
Q3 		$52.6M Buy
3,139,402
+16,890
+0.5% +$302K ﹤0.01% 1386
2021
Q2 		$38.5M Buy
+3,122,512
New +$48.5M ﹤0.01% 1556

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments's VERA Position: Q2 2026 in Review

Fidelity Investments increased its Vera Therapeutics (VERA) stake by 3.6% in Q2 2026, buying an estimated $3.64M and bringing the position to 2,774,070 shares worth $119M. The position accounts for 0.01% of the portfolio, ranked #1166.

Fidelity Investments first reported a position in VERA in Q2 2021 and has held it in 21 quarters since. The position peaked at $146M in Q4 2025. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Fidelity Investments held 2,774,070 shares of Vera Therapeutics worth $119M as of Q2 2026.
  • Fidelity Investments bought 97,648 Vera Therapeutics shares in Q2 2026, an estimated $3.64M.
  • Vera Therapeutics made up 0.01% of Fidelity Investments's portfolio in Q2 2026, its #1166 holding.
  • Fidelity Investments first reported a position in Vera Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • Fidelity Investments's Vera Therapeutics position peaked at $146M in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.